Evan Scott Stolove Net Worth

The estimated Net Worth of Evan Stolove is at least $969 Thousand dollars as of 9 February 2024. Mr Stolove owns over 6,506 units of Enact Inc stock worth over $304,296 and over the last 3 years he sold ACT stock worth over $0. In addition, he makes $664,692 as Exec. VP and Gen. Counsel & Sec. at Enact Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Stolove ACT stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Enact Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 6,506 units of ACT stock worth $228,556 on 9 February 2024.

The largest trade he's ever made was exercising 6,506 units of Enact Inc stock on 9 February 2024 worth over $228,556. On average, Mr trades about 544 units every 20 days since 2021. As of 9 February 2024 he still owns at least 8,662 units of Enact Inc stock.

You can see the complete history of Mr Stolove stock trades at the bottom of the page.

Mr. Evan Scott Stolove biography

Evan Scott Stolove is the Exec. VP, Gen. Counsel & Sec. at Enact Inc.

What is the salary of Mr Stolove?

As the Exec. VP and Gen. Counsel & Sec. of Enact Inc, the total compensation of Mr Stolove at Enact Inc is $664,692. There are 2 executives at Enact Inc getting paid more, with Rohit Gupta having the highest compensation of $3,175,003.

How old is Mr Stolove?

Mr Stolove is 52, he's been the Exec. VP and Gen. Counsel & Sec. of Enact Inc since . There are no older and 6 younger executives at Enact Inc.

What's Mr Stolove's mailing address?

Evan's mailing address filed with the SEC is C/O ENACT HOLDINGS, INC., 8325 SIX FORKS ROAD, RALEIGH, NC, 27615.

Insiders trading at Enact Inc

Over the last 12 years, insiders at Enact Inc have traded over $742,398,702 worth of Enact Inc stock and bought 189,956 units worth $3,738,670 . The most active insiders traders include Holdings, Inc. Genworth, Daniel J Iv Sheehan, and Michael A Bless. On average, Enact Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,061,714. The most recent stock trade was executed by Holdings, Inc. Genworth on 30 August 2024, trading 697,093 units of ACT stock currently worth $23,401,412.

What does Enact Inc do?

Enact Holdings, Inc. operates as a holding company. Through its subsidiaries, Enact provides mortgage insurance services to mortgage lenders and investors.

Complete history of Mr Stolove stock trades at Enact Inc

Enact Inc executives and stock owners

Enact Inc executives and other stock owners filed with the SEC include:

• Rohit Gupta,
  Pres, CEO & Director
• Hardin Dean Mitchell,
  EVP, CFO & Treasurer
• Evan Scott Stolove,
  Exec. VP, Gen. Counsel & Sec.
• Piotr Bielinski,
  Chairman of the Management Board
• Slawomir Harazin,
  Vice Chairman of the Management Board
• Iwona Bocianowska,
  Chairwoman of the Supervisory Board
• Krzysztof Kaczmarczyk,
  Member of the Supervisory Board
• Piotr Chajderowski,
  Independent Member of the Supervisory Board
• Marek Jakubowski,
  Secretary of the Supervisory Board
• Adam Switalski,
  Independent Vice Chairman of the Supervisory Board
• Anna Bielinska,
  Director of Public Relations and Investor Relations
• Andrzej Bialy,
  Finance Director
• James Robert McMullen,
  Controller
• Michael Paul Derstine,
  Exec. VP & Chief Risk Officer
• Brian Michael Gould,
  EVP & COO
• Rohit Gupta,
  President and CEO
• Brian Gould,
  EVP & Chief Operations Officer
• James Mc Mullen,
  Controller
• Hardin Dean Mitchell,
  EVP, CFO and Treasurer
• Evan Stolove,
  EVP, Gen. Counsel & Secretary
• Michael Derstine,
  EVP and Chief Risk Officer
• Fred G Weiss,
  Director
• Ronald R Taylor,
  Director
• Jack Michelson,
  Director
• Cathy Klema,
  Director
• Andrew L Turner,
  Director
• Albert F Hummel,
  Director
• Michael J Fedida,
  Director
• George Fred Wilkinson,
  Pres-Global Brands&Biosimilars
• Michel J Feldman,
  Director
• R Todd Joyce,
  CFO-Global & PAO
• Sigurdur O Olafsson,
  Pres-Global Generics
• Chris W Bodine,
  Director
• Robert A Stewart,
  Pres-Global Operations
• Albert Iii Paonessa,
  President of Anda, Inc.
• Charles M Mayr,
  Chief Communic Off-Global
• Charles D Ebert,
  Sr. VP, Research & Development
• David A Buchen,
  Chief Legal Officer-Global&Sec
• Hafrun Fridriksdottir,
  Sr VP,Global Generics R&D
• Patrick Eagan,
  Chief HR Officer - Global
• Paul Bisaro,
  President & CEO
• Dominic James Addesso,
  Director
• Robert P Jr Restrepo,
  Director
• John D Fisk,
  Director
• Anne G Waleski,
  Director
• Westley V Thompson,
  Director
• Daniel J Iv Sheehan,
  Director
• Debra Still,
  Director
• Holdings, Inc. Genworth,
  
• Michael A Bless,
  Director
• Raymond T Odierno,
  Director
• Sheila Hooda,
  Director